Researcher Profiles

Return to member profile

Isaac Yi Kim, MD, PhD

Publications since 2011

Faiena, I. Singer, E. A. Pumill, C. Kim, I. Y. Cytoreductive prostatectomy: Evidence in support of a new surgical paradigm (Review). Int J Oncol, 45:2193-2198, . (PMID: 25340386)

Yun, S. J. Yan, C. Jeong, P. Kang, H. W. Kim, Y. H. Kim, E. A. Lee, O. J. Kim, W. T. Moon, S. K. Kim, I. Y. Choi, Y. H. Kim, W. J. Comparison of mRNA, Protein, and Urinary Nucleic Acid Levels of S100A8 and S100A9 between Prostate Cancer and BPH. Ann Surg Oncol, In process, . (PMID: 25348783)

Ha, Y. S. Yu, J. Salmasi, A. H. Patel, N. Parihar, J. Singer, E. A. Kim, J. H. Kwon, T. G. Kim, W. J. Kim, I. Y. Prostate-specific Antigen Density Toward a Better Cutoff to Identify Better Candidates for Active Surveillance. Urology, 84:365-372, . (PMID: 24925834)

Ha, Y. S. Kim, I. Y. Enzalutamide: looking back at its preclinical discovery. Expert Opin Drug Discov, 9:837-845, . (PMID: 24820058)

Ha, Y. S. Kang, D. I. Kim, J. H. Joung, J. Y. Yu, J. Parihar, J. S. Salmasi, A. H. Horie, S. Kim, W. J. Yi Kim, I. Favorable risk factors in patients with positive surgical margin after robot-assisted radical prostatectomy. Can J Urol, 21:7290-7297, . (PMID: 24978359)

Kang, H. W. Tchey, D. U. Yan, C. Kim, W. T. Kim, Y. J. Yun, S. J. Lee, S. C. Choi, Y. H. Kim, I. Y. Kim, W. J. The predictive value of GSTT1 polymorphisms in predicting the early response to induction BCG therapy in patients with non-muscle invasive bladder cancer. Urol Oncol, 32:458-465, . (PMID: 24411789)

Jin, X. Yun, S. J. Jeong, P. Kim, I. Y. Kim, W. J. Park, S. Diagnosis of bladder cancer and prediction of survival by urinary metabolomics. Oncotarget, 5:1635-1645, . (PMID: 24721970, PMCID: PMC4039236)

Lee, G. T. Kang, D. I. Ha, Y. S. Jung, Y. S. Chung, J. Min, K. Kim, T. H. Moon, K. H. Chung, J. M. Lee, D. H. Kim, W. J. Kim, I. Y. Prostate cancer bone metastases acquire resistance to androgen deprivation via WNT5A-mediated BMP-6 induction. Br J Cancer, 110:1634-1644, . (PMID: 24518599, PMCID: PMC3960605)

Kim, Y. H. Kim, W. T. Jeong, P. Ha, Y. S. Kang, H. W. Yun, S. J. Moon, S. K. Choi, Y. H. Kim, I. Y. Kim, W. J. Novel Combination Markers for Predicting Survival in Patients with Muscle Invasive Bladder Cancer: USP18 and DGCR2. J Korean Med Sci, 29:351-356, . (PMID: 24616583, PMCID: PMC3945129)

Hong, J. H. Kim, I. Y. Nonmetastatic Castration-Resistant Prostate Cancer. Korean J Urol, 55:153-160, . (PMID: 24648868, PMCID: PMC3956942)

Parihar, J. S. Ha, Y. S. Kim, I. Y. Bladder neck contracture-incidence and management following contemporary robot assisted radical prostatectomy technique. Prostate Int, 2:12-18, . (PMID: 24693529, PMCID: PMC3970984)

Lee, G. T. Ha, Y. S. Jung, Y. S. Moon, S. K. Kang, H. W. Lee, O. J. Joung, J. Y. Choi, Y. H. Yun, S. J. Kim, W. J. Kim, I. Y. DHCR24 is an Independent Predictor of Progression in Patients with Non-Muscle-Invasive Urothelial Carcinoma, and Its Functional Role is Involved in the Aggressive Properties of Urothelial Carcinoma Cells. Ann Surg Oncol, In process, . (PMID: 24562935)

Woo, S. H. Kang, D. I. Ha, Y. S. Salmasi, A. H. Kim, J. H. Lee, D. H. Kim, W. J. Kim, I. Y. Comprehensive Analysis of Sexual Function Outcome in Prostate Cancer Patients after Robot-Assisted Radical Prostatectomy. J Endourol, 28:172-177, . (PMID: 23987521)

Bansal, N. Davis, S. Tereshchenko, I. Budak-Alpdogan, T. Zhong, H. Stein, M. N. Kim, I. Y. Dipaola, R. S. Bertino, J. R. Sabaawy, H. E. Enrichment of human prostate cancer cells with tumor initiating properties in mouse and zebrafish xenografts by differential adhesion. Prostate, 74:187-200, . (PMID: 24154958, PMCID: PMC3939797)

Kwon, S. J. Lee, G. T. Lee, J. H. Iwakura, Y. Kim, W. J. Kim, I. Y. Mechanism of pro-tumorigenic effect of BMP-6: neovascularization involving tumor-associated macrophages and IL-1a. Prostate, 74:121-133, . (PMID: 24185914)

Kang, J. H. Ha, Y. S. Kim, S. Yu, J. Patel, N. Parihar, J. S. Salmasi, A. H. Kim, W. J. Kim, I. Y. Concern for overtreatment using the AUA/ASTRO guideline on adjuvant radiotherapy after radical prostatectomy. BMC Urol, 14:30, . (PMID: 24708639, PMCID: PMC4005471)

Ha, Y. S. Lee, G. T. Kim, Y. H. Kwon, S. Y. Choi, S. H. Kim, T. H. Kwon, T. G. Yun, S. J. Kim, I. Y. Kim, W. J. Decreased selenium-binding protein 1 mRNA expression is associated with poor prognosis in renal cell carcinoma. World J Surg Oncol, 12:288, . (PMID: 25227434, PMCID: PMC4176564)

Kang, H. W. Yang, J. B. Kwon, W. A. Lee, Y. S. Kim, W. T. Kim, Y. J. Yun, S. J. Lee, S. C. Kim, I. Y. Kim, W. J. Diagnostic role of prostate resection in the elderly patients who experience significant co-morbidity with a high clinical suspicion of prostate cancer. J Korean Med Sci, 28:1796-1800, . (PMID: 24339711, PMCID: PMC3857377)

Joung, J. Y. Ha, Y. S. Singer, E. A. Ercolani, M. C. Favaretto, R. L. Lee, D. H. Kim, W. J. Lee, K. H. Kim, I. Y. Use of a Hyaluronic Acid-Carboxymethylcellulose Adhesion Barrier on the Neurovascular Bundle and Prostatic Bed to Facilitate Earlier Recovery of Erectile Function After Robot-Assisted Prostatectomy: An Initial Experience. J Endourol, 27:1230-1235, . (PMID: 23879531)

Kim, I. Y. Editorial comment. Urology, 82:583, . (PMID: 23876585)

Shim, U. J. Lee, I. S. Kang, H. W. Kim, J. Kim, W. T. Kim, I. Y. Ryu, K. H. Choi, Y. H. Moon, S. K. Kim, Y. J. Yun, S. J. Lee, S. C. Kim, W. J. Decreased DBC1 Expression Is Associated With Poor Prognosis in Patients With Non-Muscle-Invasive Bladder Cancer. Korean J Urol, 54:631-637, . (PMID: 24044099, PMCID: PMC3773595)

Kim, Y. J. Yoon, H. Y. Kim, J. S. Kang, H. W. Min, B. D. Kim, S. K. Ha, Y. S. Kim, I. Y. Ryu, K. H. Lee, S. C. Kim, W. J. HOXA9, ISL1 and ALDH1A3 methylation patterns as prognostic markers for nonmuscle invasive bladder cancer: array-based DNA methylation and expression profiling. Int J Cancer, 133:1135-1142, . (PMID: 23436614)

Kim, I. Y. Ohtsuki, C. Coughlan, A. Placek, L. Wren, A. W. Towler, M. R. Characteristics of glass ionomer cements composed of glass powders in CaO-SrO-ZnO-SiO system prepared by two different synthetic routes. J Mater Sci Mater Med, In process, . (PMID: 23918526)

Kim, J. H. Ha, Y. S. Jeong, S. J. Kim, S. Kim, W. J. Jang, T. L. Kim, I. Y. Factors related to patient-perceived satisfaction after robot-assisted radical prostatectomy based on the expanded prostate cancer index composite survey. Prostate Cancer Prostatic Dis, In process, . (PMID: 23917307)

Kim, I. Y. Modi, P. K. Sadimin, E. Ha, Y. S. Kim, J. H. Skarecky, D. Cha, D. Y. Wambi, C. O. Ou, Y. C. Yuh, B. Park, S. Llukani, E. Albala, D. M. Wilson, T. Ahlering, T. Badani, K. Ahn, H. Lee, D. I. May, M. Kim, W. J. Lee, D. H. Detailed Analysis of Prostate Cancer Patients with Metastasis to the Prostatic Anterior Fat Pad Lymph Nodes: a Multi-Institution Study. J Urol, 190:527-534, . (PMID: 23485503)

Joung, J. Y. Ha, Y. S. Kim, I. Y. Radium Ra 223 dichloride in castration-resistant prostate cancer. Drugs Today (Barc), 49:483-490, . (PMID: 23977665)

Lee, G. T. Jung, Y. S. Ha, Y. S. Kim, J. H. Kim, W. J. Kim, I. Y. Bone morphogenetic protein-6 induces castration resistance in prostate cancer cells through tumor infiltrating macrophages. Cancer Sci, 104:1027-1032, . (PMID: 23710822)

Lee, J. H. Lee, G. T. Woo, S. H. Ha, Y. S. Kwon, S. J. Kim, W. J. Kim, I. Y. Bone Morphogenetic Protein-6 in Renal Cell Carcinoma Promotes Tumor Proliferation via M2 Polarization of Tumor-Infiltrating Macrophages through Interleukin-10. Cancer Res, 73:3604-3614, . (PMID: 23633487)

Shao, Y. H. Kim, S. Moore, D. F. Shih, W. Lin, Y. Stein, M. Kim, I. Y. Lu-Yao, G. L. Cancer-specific Survival After Metastasis Following Primary Radical Prostatectomy Compared with Radiation Therapy in Prostate Cancer Patients: Results of a Population-based, Propensity Score-Matched Analysis. Eur Urol, In process, . (PMID: 23759328)

Kim, J. H. Ha, Y. S. Jeong, S. J. Lee, D. H. Kim, W. J. Kim, I. Y. Impact of Robot-assisted Radical Prostatectomy on Lower Urinary Tract Symptoms and Predictive Factors for Symptom Changes: A Longitudinal Study. Urology, 81:787-793, . (PMID: 23434100)

Ha, Y. S. Salmasi, A. Karellas, M. Singer, E. A. Kim, J. H. Han, M. Partin, A. W. Kim, W. J. Lee, D. H. Kim, I. Y. Increased Incidence of Pathologically Nonorgan Confined Prostate Cancer in African-American Men Eligible for Active Surveillance. Urology, 81:831-835, . (PMID: 23465143)

Jung, S. J. Oh, S. Lee, G. T. Chung, J. Min, K. Yoon, J. Kim, W. Ryu, D. S. Kim, I. Y. Kang, D. I. Clinical Significance of Wnt/beta-Catenin Signalling and Androgen Receptor Expression in Prostate Cancer. World J Mens Health, 31:36-46, . (PMID: 23658864, PMCID: PMC3640151)

Kim, I. Y. Reply. Urology, In process, . (PMID: 23465146)

Ha, Y. S. Goodin, S. Dipaola, R. S. Kim, I. Y. Enzalutamide for the treatment of castration-resistant prostate cancer. Drugs Today (Barc), 49:7-13, . (PMID: 23362491)

Park, H. J. Ha, Y. S. Park, S. Y. Kim, Y. T. Lee, T. Y. Kim, J. H. Lee, D. H. Kim, W. J. Kim, I. Y. Incidence of Upgrading and Upstaging in Patients with Low-Volume Gleason Score 3+4 Prostate Cancers at Biopsy: Finding a New Group Eligible for Active Surveillance. Urol Int, 90:301-305, . (PMID: 23391718)

Ha, Y. S. Chihara, Y. Yoon, H. Y. Kim, Y. J. Kim, T. H. Woo, S. H. Yun, S. J. Kim, I. Y. Hirao, Y. Kim, W. J. Downregulation of fumarate hydratase is related to tumorigenesis in sporadic renal cell cancer. Urol Int, 90:233-239, . (PMID: 23295344)

Kang, D. I. Chung, J. I. Ha, H. K. Min, K. Yoon, J. Kim, W. Seo, W. I. Kang, P. m. Jung, S. J. Kim, I. Y. Korean prostate cancer patients have worse disease characteristics than their American counterparts. Asian Pac J Cancer Prev, 14:6913-6917, . (PMID: 24377625)

Yun, S. J. Yoon, H. Y. Bae, S. C. Lee, O. J. Choi, Y. H. Moon, S. K. Kim, I. Y. Kim, W. J. Transcriptional repression of RUNX2 is associated with aggressive clinicopathological outcomes, whereas nuclear location of the protein is related to metastasis in prostate cancer. Prostate Cancer Prostatic Dis, 15:369-373, . (PMID: 22890388)

Jeong, P. Min, B. D. Ha, Y. S. Song, P. H. Kim, I. Y. Ryu, K. H. Kim, J. H. Yun, S. J. Kim, W. J. RUNX3 methylation in normal surrounding urothelium of patients with non-muscle-invasive bladder cancer: potential role in the prediction of tumor progression. Eur J Surg Oncol, 38:1095-1100, . (PMID: 22884471)

Yun, S. J. Jeong, P. Kim, W. T. Kim, T. H. Lee, Y. S. Song, P. H. Choi, Y. H. Kim, I. Y. Moon, S. K. Kim, W. J. Cell-free microRNAs in urine as diagnostic and prognostic biomarkers of bladder cancer. Int J Oncol, 41:1871-1878, . (PMID: 22961325)

Kim, J. J. Ha, Y. S. Kim, J. H. Jeon, S. S. Lee, D. H. Kim, W. J. Kim, I. Y. Independent predictors of recovery of continence 3 months after robot-assisted laparoscopic radical prostatectomy. J Endourol, 26:1290-1295, . (PMID: 22651546, PMCID: PMC3466068)

Lee, J. H. Lee, G. T. Kwon, S. J. Jeong, J. Ha, Y. S. Kim, W. J. Kim, I. Y. CREBZF, a novel Smad8-binding protein. Mol Cell Biochem, 368:147-153, . (PMID: 22707059)

Kim, E. J. Yan, C. Ha, Y. S. Jeong, P. Yi Kim, I. Moon, S. K. Choi, Y. H. Kim, W. J. Analysis of hOGG1 genotype as a prognostic marker for muscle invasive bladder cancer: a novel approach using peptide nucleic acid-mediated, real-time PCR clamping. Urol Oncol, 30:673-679, . (PMID: 20884250)

Ha, Y. S. Kim, J. S. Yoon, H. Y. Jeong, P. Kim, T. H. Yun, S. J. Lee, S. C. Kim, G. Y. Choi, Y. H. Moon, S. K. Yi Kim, I. Kim, W. J. Novel combination markers for predicting progression of nonmuscle invasive bladder cancer. Int J Cancer, 131:E501-E507, . (PMID: 22025348)

Kang, D. I. Woo, S. H. Lee, D. H. Kim, I. Y. Incidence of Port-Site Hernias After Robot-Assisted Radical Prostatectomy with the Fascial Closure of Only the Midline 12-mm Port Site. J Endourol, 26:848-851, . (PMID: 22283233)

Ha, Y. S. Jeong, P. Kim, J. S. Kwon, W. A. Kim, I. Y. Yun, S. J. Kim, G. Y. Choi, Y. H. Moon, S. K. Kim, W. J. Tumorigenic and prognostic significance of RASSF1A expression in low-grade (WHO grade 1 and grade 2) nonmuscle-invasive bladder cancer. Urology, 79:1411.e1-1411.e6, . (PMID: 22446336)

Kim, J. S. Chae, Y. Ha, Y. S. Kim, I. Y. Byun, S. S. Yun, S. J. Kim, W. J. Ras association domain family 1A: a promising prognostic marker in recurrent nonmuscle invasive bladder cancer. Clin Genitourin Cancer, 10:114-120, . (PMID: 22382007)

Yan, C. Kim, Y. W. Ha, Y. S. Kim, I. Y. Kim, Y. J. Yun, S. J. Moon, S. K. Bae, S. C. Kim, W. J. RUNX3 methylation as a predictor for disease progression in patients with non-muscle-invasive bladder cancer. J Surg Oncol, 105:425-430, . (PMID: 22311819)

Yun, S. J. Ha, Y. S. Chae, Y. Kim, J. S. Kim, I. Y. Kim, W. J. The hOGG1 mutant genotype is associated with prostate cancer susceptibility and aggressive clinicopathological characteristics in the Korean population. Ann Oncol, 23:401-405, . (PMID: 21515665)

Chou, Y. W. Chaturvedi, N. K. Ouyang, S. Lin, F. F. Kaushik, D. Wang, J. Kim, I. Lin, M. F. Histone deacetylase inhibitor valproic acid suppresses the growth and increases the androgen responsiveness of prostate cancer cells. Cancer Lett, 311:177-186, . (PMID: 21862211, PMCID: PMC3232184)

Kang, D. I. Jang, T. L. Jeong, J. Choi, E. Y. Johnson, K. Lee, D. H. Kim, W. J. Kim, I. Y. Pathological findings following radical prostatectomy in patients who are candidates for active surveillance: impact of varying PSA levels. Asian J Androl, 13:838-841, . (PMID: 21785442)

Kim, W. T. Yun, S. J. Choi, Y. D. Kim, G. Y. Moon, S. K. Choi, Y. H. Kim, I. Y. Kim, W. J. Prostate size correlates with fasting blood glucose in non-diabetic benign prostatic hyperplasia patients with normal testosterone levels. J Korean Med Sci, 26:1214-1218, . (PMID: 21949470, PMCID: PMC3173509)

Kim, W. T. Choi, Y. D. Park, C. Kim, Y. W. Yun, S. J. Kim, I. Y. Kim, W. J. Parathyroid hormone is not involved in prostate growth in patients with benign prostatic hyperplasia. Prostate, 71:1210-1215, . (PMID: 21656831)

Lee, G. T. Jung, Y. S. Lee, J. H. Kim, W. J. Kim, I. Y. Bone morphogenetic protein 6-induced interleukin-1beta expression in macrophages requires PU.1/Smad1 interaction. Mol Immunol, 48:1540-1547, . (PMID: 21571370)

Kim, Y. J. Yoon, H. Y. Kim, S. K. Kim, Y. W. Kim, E. J. Kim, I. Y. Kim, W. J. EFEMP1 as a novel DNA methylation marker for prostate cancer: array-based DNA methylation and expression profiling. Clin Cancer Res, 17:4523-4530, . (PMID: 21571867)

Jeong, P. Ha, Y. S. Cho, I. C. Yun, S. J. Yoo, E. S. Kim, I. Y. Choi, Y. H. Moon, S. K. Kim, W. J. Three-gene signature predicts disease progression of non-muscle invasive bladder cancer. Oncol Lett, 2:679-684, . (PMID: 22848249, PMCID: PMC3406413)

Woo, S. H. Kim, I. Y. Editorial comment for Rebuck et al. J Endourol, 25:960-961, . (PMID: 21574865)

Kim, W. J. Kim, S. K. Jeong, P. Yun, S. J. Cho, I. C. Kim, I. Y. Moon, S. K. Um, H. D. Choi, Y. H. A four-gene signature predicts disease progression in muscle invasive bladder cancer. Mol Med, 17:478-485, . (PMID: 21308147, PMCID: PMC3105150)

Jeong, J. Choi, E. Y. Kang, D. I. Ercolani, M. Lee, D. H. Kim, W. J. Kim, I. Y. Pathologic implications of prostatic anterior fat pad. Urol Oncol, In process, . (PMID: 21396837)

Lee, G. T. Kwon, S. J. Lee, J. H. Jeon, S. S. Jang, K. T. Choi, H. Y. Lee, H. M. Kim, W. J. Lee, D. H. Kim, I. Y. Macrophages induce neuroendocrine differentiation of prostate cancer cells via BMP6-IL6 Loop. Prostate, In process, . (PMID: 21374653)

Choi, E. Y. Jeong, J. Kang, D. I. Johnson, K. Ercolani, M. Jang, T. Lee, D. H. Kim, W. J. Kim, I. Y. Impact of robot-assisted radical prostatectomy on health-related quality of life in patients with lower urinary tract symptoms. Int J Urol, In process, . (PMID: 21342297)

Ha, Y. S. Yan, C. Jeong, P. Kim, W. T. Yun, S. J. Kim, I. Y. Moon, S. K. Kim, W. J. GSTM1 tissue genotype as a recurrence predictor in non-muscle invasive bladder cancer. J Korean Med Sci, 26:231-236, . (PMID: 21286014, PMCID: PMC3031007)